A One Day Seminar on Intellectual Property and Licensing Agreements in Pharmaceutical Industry

Events

On April 5, 2022
[et_pb_dcsbcm_divi_breadcrumbs_module separator="sep-tilde" _builder_version="4.6.1" _module_preset="default" body_font="Open Sans||||||||" fontsseparator_font="||||||||" fontsseparator_font_size="12px" fontsbreadcrumblinks_font="Open Sans||||||||" custom_padding="5px||5px||true|false" hover_enabled="0" body_font_size="15px" sticky_enabled="0"][/et_pb_dcsbcm_divi_breadcrumbs_module]

About the Programme:

The course will give knowledge aboutIntellectual Property and Licensing Agreements in Pharmaceutical Industry.

Participants in the program can gain a deeper understanding of the legal and business aspects of IP and licensing in the pharmaceutical industry, including the key concepts and principles, best practices, and current trends and issues.

The program can help participants develop and enhance their skills and competencies related to IP and licensing, including negotiation, drafting, and interpretation of licensing agreements, as well as strategic planning and risk management.

The program can provide opportunities for participants to network and collaborate with other professionals in the pharmaceutical industry, including experts in IP law, licensing, business development, and regulatory affairs.

By improving their understanding and skills in IP and licensing, participants can enhance their competitiveness

Objectives of the program:

  • To safeguard the investments made by companies in research and development of new drugs, this can take years and cost billions of dollars.
  • To monetize their IP assets by granting licenses to other companies to use their technology in exchange for royalties or other forms of compensation.
  • Facilitate collaboration and joint ventures between companies that have complementary technology or expertise.
  • Enable companies to access new markets by partnering with local companies that have a better understanding of the regulatory and cultural environment in those markets.
  • To mitigate the risks associated with drug development by sharing the costs and risks of research and development with other companies.

Topics to be covered:

  • Patents
  • Confidentiality and Non-Disclosure
  • License Grants and Restrictions
  • Royalties and Compensation
  • Termination and Renewal
  • Dispute Resolution
  • Representations and Warranties
  • Governing Law and Jurisdiction

Programme Committee:

Chief Patron

Chairman

Dr. P. Rajeshwar Reddy,

M.Sc, Ph.D.

Secretary and Correspondent

Patron

Dr. M. Chinna Eswaraiah,

M. Pharm, Ph.D.

Principal

Convener

Mr. K. Raveendra Babu

M. Pharm,

Assistant Professor

Department of Pharmacy Practice

Email ID: ravipharma36@gmail.com

Contact number: 99592 12028

Coordinator

Mr. T. Praveen Kumar

M. Pharm,

Assistant Professor,

Department of Pharmaceutics,

Email ID: praveensuri1@gmail.com

Contact number: 9100337332

Resource Person:

Ms. Y. Sushma,

M. Pharm,

Assistant Professor,

Department of Pharmacognosy,

G.Pulla Reddy College of Pharmacy, Hyderabad, Telangana.

Email ID: sushmayarkala@gmail.com

Contact number: 9347224897

Address for Communication:

Mr. T. Praveen Kumar

M. Pharm,

Assistant Professor,

Department of Pharmaceutics,

Email ID: praveensuri1@gmail.com

Contact number: 9100337332

Last date to Registration: 30/03/2022

Related Articles

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *